文献速递糖尿病肥胖与代谢综合征

2型糖尿病确诊2年内减重至少15%与较低的大血管和微血管并发症风险相关:英国队列研究

Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study.
PubMed 文献 · Diabetes Care · 2026-01-01

该英国队列研究(2000-2024)纳入肥胖2型糖尿病成人,比较确诊2年内减重≥15%者与体重稳定者,倾向性评分1:4匹配后分析。结果显示减重组首发大血管事件(HR 0.86,95%CI 0.81-0.91)和微血管事件(HR 0.90,95%CI 0.86-0.94)风险显著更低,且血糖和血压控制更佳。

要点

  • 确诊2年内减重≥15%与大血管并发症风险降低14%相关(HR 0.86)。
  • 减重组血糖和血压更优,尽管用药更少。

核心结论

  • 2型糖尿病早期实现≥15%减重与临床意义显著的大血管和微血管并发症风险降低相关,且血糖控制更佳。

研究设计与样本

  • 基于英国临床实践研究数据链Aurum(2000-2024)的队列研究,纳入肥胖2型糖尿病成人,减重≥15%者按1:4倾向性评分匹配至体重稳定(变化<2%)对照。

主要发现

  • 匹配队列包括14,496例减重≥15%者和57,984例对照。
  • 减重组首发大血管事件风险显著更低(HR 0.86,95%CI 0.81-0.91)。
  • 减重组首发微血管事件风险显著更低(HR 0.90,95%CI 0.86-0.94)。
  • 心肌梗死、心绞痛、慢性肾脏病和视网膜病变风险显著降低。
  • 减重组血糖和血压水平更优,尽管用药更少。

临床怎么用

  • 支持将早期、大幅减重作为2型糖尿病核心治疗策略,以改善血糖控制和预防终末器官损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate whether achieving a minimum of 15% weight loss early after type 2 diabetes diagnosis was associated with subsequent lower risks of developing macrovascular and microvascular complications. RESEARCH DESIGN AND METHODS: Using U.K. primary care data from Clinical Practice Research Datalink Aurum linked to hospital and mortality data, we conducted a cohort study (2000-2024) of adults with obesity and type 2 diabetes. Individuals with ≥15% weight loss within 2 years of type 2 diabetes diagnosis were propensity score matched 1:4 to control subjects maintaining a stable weight (<2% weight change). Cumulative incidence rates were determined, and time to first macrovascular (myocardial infarction, stroke, angina, peripheral arterial disease) and microvascular (chronic kidney disease, retinopathy, neuropathy) events was analyzed using Cox proportional hazards regression. RESULTS: The matched cohort included 14,496 individuals with ≥15% weight loss and 57,984 control subjects. Compared with control subjects, the weight loss group had significantly lower risk of first macrovascular (hazard ratio 0.86, 95% CI 0.81-0.91) and microvascular (hazard ratio 0.90, 95% CI 0.86-0.94) events. Individually, significantly lower risks were observed for myocardial infarction, angina, chronic kidney disease, and retinopathy. The weight loss group also demonstrated better glycemic and blood pressure levels, despite fewer medications. CONCLUSIONS: Achieving ≥15% weight loss early in type 2 diabetes was associated with clinically meaningful lower risks for macro- and microvascular complications and better glycemic control compared with stable weight. These real-world findings support prioritizing early, substantial weight reduction as a core therapeutic strategy to improve glycemic control and prevent end-organ damage.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Johnsen E, Bengtsson J, Halasa T, et al. Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study. Diabetes Care. 2026. PMID: 42258754. doi:10.2337/dc26-0937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。